| Sally Adams, | |
|
1300 Woodland Ave, West Des Moines, IA 50265-2306 | |
| (515) 280-3860 | |
| Not Available |
| Full Name | Sally Adams |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1300 Woodland Ave, West Des Moines, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073247318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 22142 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sally Adams, 1300 Woodland Ave, West Des Moines, IA 50265-2306 Ph: (515) 280-3860 | Sally Adams, 1300 Woodland Ave, West Des Moines, IA 50265-2306 Ph: (515) 280-3860 |
News Archive
Macmillan skin cancer nurse specialists will be promoting sun awareness and the dangers of skin cancer during Sun Awareness Week which runs from 10 to 16 May.
One of the blind spots in forensic science, particularly in identifying unknown remains, is the inability of experts to determine how much an individual weighed based on his or her skeleton.
Low blood phosphorus levels are associated with high death rates in the initial weeks of antiretroviral therapy (ART) in AIDS patients in sub-Saharan Africa, according to new research conducted by University of Alabama at Birmingham researchers at the UAB-affiliated Centre for Infectious Disease Research in Zambia.
LTC Properties, Inc. announced today that it had declared the quarterly cash dividend of $0.50 per share on the Company's 8.0% Series F Cumulative Preferred Stock. The dividend is payable on October 15, 2010 to stockholders of record on October 1, 2010.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
› Verified 1 days ago
Maria Jose Andonie, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1001 Office Park Rd Ste 205, West Des Moines, IA 50265 Phone: 515-471-2341 Fax: 515-284-5201 | |
Bill David Cunigan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1200 Valley West Dr, Suite 306, West Des Moines, IA 50266 Phone: 515-267-1340 Fax: 515-267-1355 | |
Amy J. Ugulini Pals, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1200 Valley West Dr Ste 204, West Des Moines, IA 50266 Phone: 515-518-0412 | |
Gabrielle Llewellyn, MFT-T Counselor Medicare: Not Enrolled in Medicare Practice Location: 1701 48th St Ste 120, West Des Moines, IA 50266 Phone: 515-331-0303 | |
Brooke N. Benham, LPC; LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1200 Valley West Drive, West Des Moines, IA 50322 Phone: 515-267-1340 Fax: 515-267-1355 | |
Ellen M. Folkers-jenkins, LMHC, CADC Counselor Medicare: Medicare Enrolled Practice Location: 1300 Woodland Ave, West Des Moines, IA 50265 Phone: 515-280-4931 Fax: 515-883-2683 | |
Sara Coen, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1501 42nd St Ste 210, West Des Moines, IA 50266 Phone: 515-669-7861 |